Abstract
Multiple acyl-CoA dehydrogenase deficiency (MADD) type II has neonatal onset without congenital anomalies. In those who survive the neonatal period, recurrent metabolic decompensation and hypertrophic cardiomyopathy can occur. Deficiency of the electron transfer flavoprotein (ETF alpha and beta subunits, ETFA and ETFB) or the ETF flavin adenine dinucleotide (FAD)-dependent dehydrogenase (ETFDH) negatively impacts electron transfer in the mitochondria which subsequently affects fatty acid oxidation (FAO) and the metabolism of some amino acids.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
